Noiruimunbaiotekku
4893.TTSE GROWTHPharmaceutical
Filed as Noile-Immune Biotech Inc. (2023-08–2026-08)
Financials · Consolidated
No consolidated annual figures structured yet.
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 10
| Period | Form | Figures |
|---|---|---|
| 2026-01-01 → 2026-06-30 | Half-year | 61 figures · EDINET |
| 2025-01-01 → 2025-12-31 | Annual | 105 figures · EDINET |
| 2025-01-01 → 2025-06-30 | Half-year | 61 figures · EDINET |
| 2024-01-01 → 2024-12-31 | Annual | 104 figures · EDINET |
| 2024-01-01 → 2024-06-30 | Half-yearAmended | 61 figures · EDINET |
| 2024-01-01 → 2024-06-30 | Half-year | 61 figures · EDINET |
| 2024-01-01 → 2024-03-31 | Quarterly Q1 | 37 figures · EDINET |
| 2023-01-01 → 2023-12-31 | Annual | 100 figures · EDINET |
| 2023-01-01 → 2023-09-30 | Quarterly Q3 | 27 figures · EDINET |
| 2023-01-01 → 2023-06-30 | Quarterly Q2 | 40 figures · EDINET |